WebMar 9, 2024 · Latest Rebus Holdings Inc Stock News. As of March 09, 2024, Rebus Holdings Inc had a $0.2 million market capitalization, putting it in the 1st percentile of companies in the Biotechnology & Medical Research industry. Rebus Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Web2 days ago · About RBSH. Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
RBS Share Forecast, Price & News (Royal Bank of Scotland Group)
WebMar 30, 2024 · The Rebus Holdings, Inc. stock price fell by -25.00% on the last day (Thursday, 30th Mar 2024) from $0.0200 to $0.0150. During the last trading day the stock … WebLooking back, over the last four weeks, Royal Bank lost 0.42 percent. Over the last 12 months, its price rose by 17.62 percent. Looking ahead, we forecast Royal Bank to be priced at 244.76 by the end of this quarter and at 227.91 in one year, according to Trading Economics global macro models projections and analysts expectations. Royal Bank. see you by then meaning
Rebus Holdings, Inc. (RBSH) Stock Price, Quote & News - Stock …
WebMar 24, 2024 · Interactive Rebus Holdings, Inc. (RBSH) stock chart with full price history, volume, trends and moving averages. Web1 day ago · Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine … WebFind out the current price target and stock forecast for Inspyr Therapeutics (RBSH) ... Stocks Under $10; Value Investor; Top 10 Stocks; Other Services. Method for Trading; Research … see you in a better place